Clinical Trial Detail

NCT ID NCT02390752
Title PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

rhabdomyosarcoma

plexiform neurofibroma

malignant glioma

sarcoma

acute leukemia

medulloblastoma

central nervous system cancer

Advanced Solid Tumor

Therapies

Pexidartinib

Age Groups: adult child

No variant requirements are available.